FIGURE

Fig. 4

ID

ZDB-FIG-230704-4

Publication

McKeown et al., 2022 - Pilot Study of Jadomycin B Pharmacokinetics and Anti-Tumoral Effects in Zebrafish Larvae and Mouse Breast Cancer Xenograft Models

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Jadomycin B reduced 4T1 primary tumor growth. Adult female Balb/C mice were injected with 100 000 4T1 cells into the fourth mammary fat pad on day 0, followed by jadomycin B (Jad B) treatment (12 mg/kg every 12 h) from day 6 to 15 after tumor cell implantation. Tumor volumes were measured every 2 days (A). At the study endpoint, tumors were excised and weighed (B) and the number of lung metastasis were determined by the 6-thioguanine colony forming assay (C). The data in panel A are shown as mean ± SEM (n = 8). ^***P ≤ 0.001, compared to the respective vehicle control, as determined by a two-way repeated measures ANOVA, with Bonferroni multiple comparison test. The data in panels B and C are shown as scatter plots with mean ± SEM. The groups were compared using a non-parametric Mann–Whitney test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Can. J. Physiol. Pharmacol.